JACC. CardioOncology 2024 Apr 16
Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines: : CardioOncology Controversies in Cardio-Oncology.
Related Questions
New answer by at Weill Cornell Medicine Division Of Cardiology (June 12, 2025)
Typically considered in patients with anticipated >300 mg/m2 doxorubicin, as has been mentioned, which is most commonly seen in patients with sarcoma or recurrent lymphomas...